Literature DB >> 34526791

Understanding Competitive Endogenous RNA Network Mechanism in Type 1 Diabetes Mellitus Using Computational and Bioinformatics Approaches.

Xuanzi Yi1, Xu Cheng2,3.   

Abstract

BACKGROUND: Type 1 diabetes mellitus (T1DM), an autoimmune disease with a genetic tendency, has an increasing prevalence. Long non-coding RNA (lncRNA) and circular RNA (circRNA) are receiving increasing attention in disease pathogenesis. However, their roles in T1DM are poorly understood. The present study aimed at identifying signature lncRNAs and circRNAs and investigating their roles in T1DM using the competing endogenous RNA (ceRNA) network analysis.
METHODS: The T1DM expression profile was downloaded from Gene Expression Omnibus (GEO) database to identify the differentially expressed circRNAs, lncRNAs, and mRNAs. The biological functions of these differentially expressed circRNAs, lncRNAs, and mRNAs were analyzed by the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. Targeting relationships of circRNA-miRNA, lncRNA-miRNA, and miRNA-mRNA were predicted, and the circRNA-lncRNA-miRNA-mRNA ceRNA regulatory network was established. Finally, qRT-PCR was applied to identify the effect of hsa_circ_0002202 inhibition on the IFN-I induced macrophage inflammation.
RESULTS: A total of 178 circRNAs, 404 lncRNAs, and 73 mRNAs were identified to be abnormally expressed in T1DM samples. Functional enrichment analysis results indicated that the differentially expressed genes were mainly enriched in extracellular matrix components and macrophage activation. CeRNA regulatory network showed that circRNAs and lncRNAs regulate mRNAs through integrate multiple miRNAs. In addition, in vitro experiments showed that hsa_circ_0002202 inhibition suppressed the type I interferon (IFN-I)-induced macrophage inflammation.
CONCLUSION: In the present study, the circRNA-lncRNA-miRNA-mRNA ceRNA regulatory network in T1DM was established for the first time. We also found that hsa_circ_0002202 inhibition suppressed the IFN-I-induced macrophage inflammation. Our study may lay a foundation for future studies on the ceRNA regulatory network in T1DM.
© 2021 Yi and Cheng.

Entities:  

Keywords:  ceRNA network; macrophage; peripheral blood mononuclear cell; type 1 diabetes mellitus

Year:  2021        PMID: 34526791      PMCID: PMC8436179          DOI: 10.2147/DMSO.S315488

Source DB:  PubMed          Journal:  Diabetes Metab Syndr Obes        ISSN: 1178-7007            Impact factor:   3.168


  69 in total

1.  Effects of iPad Video Education on Patient Knowledge, Satisfaction, and Cardiac Rehabilitation Attendance.

Authors:  Julie L Wischer; Marilyn H Oermann; Inga M Zadvinskis; Kimberly C Kinney
Journal:  Qual Manag Health Care       Date:  2018 Oct/Dec       Impact factor: 0.926

2.  A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?

Authors:  Leonardo Salmena; Laura Poliseno; Yvonne Tay; Lev Kats; Pier Paolo Pandolfi
Journal:  Cell       Date:  2011-07-28       Impact factor: 41.582

Review 3.  Basic biology and therapeutic implications of lncRNA.

Authors:  O Khorkova; J Hsiao; C Wahlestedt
Journal:  Adv Drug Deliv Rev       Date:  2015-05-27       Impact factor: 15.470

4.  Natural RNA circles function as efficient microRNA sponges.

Authors:  Thomas B Hansen; Trine I Jensen; Bettina H Clausen; Jesper B Bramsen; Bente Finsen; Christian K Damgaard; Jørgen Kjems
Journal:  Nature       Date:  2013-02-27       Impact factor: 49.962

Review 5.  The nephrological perspective on SGLT-2 inhibitors in type 1 diabetes.

Authors:  Pieter Gillard; Oliver Schnell; Per-Henrik Groop
Journal:  Diabetes Res Clin Pract       Date:  2020-09-21       Impact factor: 5.602

Review 6.  Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.

Authors:  Jay S Skyler; George L Bakris; Ezio Bonifacio; Tamara Darsow; Robert H Eckel; Leif Groop; Per-Henrik Groop; Yehuda Handelsman; Richard A Insel; Chantal Mathieu; Allison T McElvaine; Jerry P Palmer; Alberto Pugliese; Desmond A Schatz; Jay M Sosenko; John P H Wilding; Robert E Ratner
Journal:  Diabetes       Date:  2016-12-15       Impact factor: 9.461

7.  Construction of competitive endogenous RNA network reveals regulatory role of long non-coding RNAs in type 2 diabetes mellitus.

Authors:  Zijing Lin; Xinyu Li; Xiaorong Zhan; Lijie Sun; Jie Gao; Yan Cao; Hui Qiu
Journal:  J Cell Mol Med       Date:  2017-06-23       Impact factor: 5.310

8.  Trends in the incidence of diabetes mellitus: results from the Global Burden of Disease Study 2017 and implications for diabetes mellitus prevention.

Authors:  Jinli Liu; Zhen-Hu Ren; Hua Qiang; Jine Wu; Mingwang Shen; Lei Zhang; Jun Lyu
Journal:  BMC Public Health       Date:  2020-09-17       Impact factor: 3.295

9.  CircSAMD4A aggravates H/R-induced cardiomyocyte apoptosis and inflammatory response by sponging miR-138-5p.

Authors:  Xiaorong Hu; Ruisong Ma; Jianlei Cao; Xianjin Du; Xinyong Cai; Yongzhen Fan
Journal:  J Cell Mol Med       Date:  2020-11-21       Impact factor: 5.310

10.  KEGG for representation and analysis of molecular networks involving diseases and drugs.

Authors:  Minoru Kanehisa; Susumu Goto; Miho Furumichi; Mao Tanabe; Mika Hirakawa
Journal:  Nucleic Acids Res       Date:  2009-10-30       Impact factor: 16.971

View more
  2 in total

1.  Potential of ATP5MG to Treat Metabolic Syndrome-Associated Cardiovascular Diseases.

Authors:  Lianyong Liu; Xinglu Zhou; Juan Chen; Xiangqi Li
Journal:  Front Cardiovasc Med       Date:  2022-07-22

Review 2.  Circular RNAs in diabetes mellitus and its complications.

Authors:  Wenqi Fan; Haipeng Pang; Zhiguo Xie; Gan Huang; Zhiguang Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-01       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.